Popular Filters
Phase 3 Trials
Janus Kinase (JAK) Inhibitor
Deucravacitinib for Psoriatic Arthritis
Recruiting1 awardPhase 3
New York, New York
This trial is testing a new medication called deucravacitinib to help people with active Psoriatic Arthritis. It aims to reduce joint pain and swelling by blocking harmful signals in the body. The study includes people who haven't tried biologic treatments or need an alternative to TNFα inhibitors. Deucravacitinib is an emerging treatment option for Psoriatic Arthritis, showing promise in recent studies.
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
Procedure
TAK-279 for Plaque Psoriasis
Recruiting1 awardPhase 3
East Windsor, New Jersey
This trial is testing a new drug called TAK-279 to see if it can help people with moderate to severe plaque psoriasis. The study will compare TAK-279 to an existing treatment called apremilast, which is approved for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. The goal is to find out if TAK-279 can better reduce the skin problems associated with this condition.
Procedure
TAK-279 for Plaque Psoriasis
Recruiting1 awardPhase 3
Fountain Valley, California
This trial is testing a new drug called TAK-279 to see if it can help people with moderate to severe plaque psoriasis. The goal is to find out if TAK-279 can reduce the skin problems better than other available treatments.
Trials With No Placebo
Corticosteroid
Enstilar Foam +1 More for Psoriasis
Recruiting5 awardsPhase 4
Louisville, Kentucky
This is a single-center, open-label study. Approximately 30 qualified subjects will be enrolled in a study lasting 20 weeks which investigates the effect of Enstilar used in combination with Otezla to treat psoriasis.
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
Phosphodiesterase 4 (PDE4) inhibitor
Apremilast for Psoriasis
Recruiting4 awardsPhase 4
Rockville, Maryland
Researchers want to find out if giving the drug Apremilast in combination with Clobetasol spray can help people clear their moderate to severe plaque psoriasis quicker than if Apremilast is used by itself.
Phosphodiesterase 4 (PDE4) Inhibitor
Apremilast for Frontal Fibrosing Alopecia
Recruiting4 awardsPhase 4
Bellevue, Washington
This is open label single side study involvement 20 patient treated with Apremilast. Each enrolled patient may be evaluated at by a dermatologist using the Lichen Planopilaris Activity Index and Frontal Fibrosing Alopecia Index. Other measures include physician global assessment, dermatology quality of life and patients analogue score for pruritus. Pt will have visits at Week 0,2,4,8,12,16,20,24
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.